MindWalk (NASDAQ:HYFT) Stock Price Down 5.8% - Here's What Happened

Key Points

• MindWalk shares fell 5.8% to $1.13, with trading volume 39% below the stock’s average daily volume.
• Analyst sentiment remains mixed but leans positive: the stock has a consensus “Moderate Buy” rating and a $5.00 target price, far above its current level.
• The company’s latest quarter missed expectations, reporting a $0.09-per-share loss versus an expected $0.05 loss and revenue of $2.73 million versus $3.25 million forecast.

MindWalk Holdings Corp. (NASDAQ:HYFT - Get Free Report) dropped 5.8% on Friday. The company traded as low as $1.10 and last traded at $1.13. 195,327 shares were traded during trading, a decline of 39% from the average daily volume of 320,022 shares. The stock had previously closed at $1.20.

Wall Street Analyst Weigh In

Several research firms recently commented on HYFT. Wall Street Zen upgraded MindWalk from a "sell" rating to a "hold" rating in a research report on Saturday, August 15th. HC Wainwright reissued a "buy" rating on shares of MindWalk in a report on Monday, July 20th. Zacks Research upgraded shares of MindWalk from a "strong sell" rating to a "hold" rating in a research note on Monday, September 21st. Finally, Weiss Ratings upgraded MindWalk from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $5.00.

MindWalk Stock Performance

The firm has a fifty day moving average of $1.34 and a 200-day moving average of $1.40. The company has a quick ratio of 1.75, a current ratio of 1.84 and a debt-to-equity ratio of 0.43. The firm has a market cap of $52.78 million, a P/E ratio of -4.35 and a beta of 0.77.

MindWalk (NASDAQ:HYFT - Get Free Report) last announced its quarterly earnings data on Monday, September 14th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.04). The firm had revenue of $2.73 million for the quarter, compared to the consensus estimate of $3.25 million. MindWalk had a negative return on equity of 133.26% and a negative net margin of 105.11%. Research analysts predict that MindWalk Holdings Corp. will post -0.28 earnings per share for the current fiscal year.

Institutional Trading of MindWalk

A hedge fund recently bought a new position in MindWalk stock. BlackRock Inc. purchased a new position in MindWalk Holdings Corp. (NASDAQ:HYFT - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 154,411 shares of the company's stock, valued at approximately $244,000. BlackRock Inc. owned about 0.33% of MindWalk as of its most recent SEC filing. 6.70% of the stock is owned by institutional investors and hedge funds.

MindWalk Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.